Pharmaids Pharmaceuticals Limited (BOM:524572)
39.87
+0.92 (2.36%)
At close: Feb 12, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.34 billion as of February 13, 2026. Its market cap has decreased by -47.95% in one year.
Market Cap
1.34B
Enterprise Value
1.53B
Revenue
248.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.87
Market Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.34B, an increase of 10,831.47%. That is a compound annual growth rate of 21.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.41B | -16.34% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aayush Wellness | 1.80B |
| Coral Laboratories | 1.75B |
| Astonea Labs | 1.68B |
| Bilcare | 1.57B |
| Sotac Pharmaceuticals | 1.37B |
| Parnax Lab | 1.36B |
| Lactose (India) | 1.28B |
| Bal Pharma | 1.17B |